Other mutations associated with the development of PC are TP53, CDKN2A, and SMAD4, all of which are tumor-suppressor genes that can be inactivated later on in the process of PC development and progression [40,41,52,53,54]. This evidence concerns the gene CDKN2A and neoplasm.